You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,089,534


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,089,534
Title:Pharmaceutical semi-solid composition of isotretinoin
Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.
Inventor(s): Vanderbist; Francis (Rhode-Saint-Genese, BE), Servais; Cecile (Mehaigne, BE), Baudier; Philippe (Brussels, BE)
Assignee: Galephar Pharmaceutical Research, Inc. (Puerto Rico 00777, unknown)
Application Number:13/713,897
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,089,534
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,089,534

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the intellectual property landscape effectively. This article will delve into the details of United States Patent 9,089,534, focusing on its scope, claims, and the broader patent landscape.

Overview of the Patent

United States Patent 9,089,534 B2 is titled "Pharmaceutical semi-solid composition of isotretinoin." This patent, granted on December 22, 2015, pertains to a specific formulation of isotretinoin, a medication commonly used to treat severe acne.

Patent Scope

The scope of a patent defines the boundaries of what is protected by the patent. It is determined by the claims, which are the legally binding descriptions of the invention.

Claim Structure

The patent includes multiple claims, each describing a different aspect of the invention. Here are some key points:

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. For example, Claim 1 describes the pharmaceutical semi-solid composition of isotretinoin, specifying the components and their proportions[5].
  • Dependent Claims: These claims refer back to and further limit the independent claims. For instance, Claim 2 depends on Claim 1 and adds additional specifications, such as the type of oil used in the composition[5].

Metrics for Measuring Patent Scope

Research suggests that patent scope can be measured using metrics such as independent claim length and independent claim count. Narrower claims, as measured by these metrics, are often associated with a higher probability of grant and a shorter examination process[3].

Claims Analysis

Independent Claim 1

The first independent claim describes the pharmaceutical semi-solid composition of isotretinoin, including:

  • Isotretinoin
  • A gelling agent
  • A solvent
  • An oil selected from a group consisting of vegetable oils, medium chain triglycerides, and combinations thereof[5].

Dependent Claims

Dependent claims further specify the composition, such as:

  • The type of gelling agent used (e.g., carbomer)
  • The concentration of isotretinoin
  • The presence of additional ingredients like preservatives or antioxidants[5].

Patent Landscape

Prior Art and Citations

To understand the patent landscape, it is essential to look at prior art and citations. The Common Citation Document (CCD) application can provide a single point of access to citation data from multiple patent offices, helping to identify relevant prior art[1].

Global Patent Family

Using the Global Dossier service, one can view the patent family for this specific application, including related applications filed at participating IP Offices. This helps in understanding how the invention is protected globally[1].

International Search Resources

The patent landscape extends beyond the U.S. Searching databases like PATENTSCOPE, provided by the World Intellectual Property Organization (WIPO), and other international patent offices, can reveal similar or related patents filed in other countries[1][4].

Search and Analysis Tools

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and analyzing patent documents. It offers enhanced access to prior art and flexible search capabilities[1].

Cooperative Patent Classification (CPC)

The CPC database allows for searching relevant classification schemes, which can help in identifying similar patents and understanding the broader patent landscape[4].

Practical Implications

Licensing and Litigation

The scope and claims of a patent can significantly impact licensing and litigation. Broader claims may lead to increased licensing and litigation costs, while narrower claims can provide clearer boundaries and reduce such costs[3].

Innovation Incentives

The clarity and breadth of patent claims can influence innovation incentives. Patents with well-defined and narrower claims tend to promote innovation by providing clear guidelines for what is protected and what is not[3].

Key Takeaways

  • Patent Scope: Defined by the claims, with narrower claims often associated with a higher probability of grant and shorter examination process.
  • Claims Analysis: Independent and dependent claims specify the invention, with dependent claims adding further details.
  • Patent Landscape: Includes prior art, global patent family, and international search resources.
  • Search and Analysis Tools: Utilize tools like Patent Public Search, CPC, and Global Dossier for comprehensive analysis.
  • Practical Implications: Clear and narrow claims can reduce licensing and litigation costs and promote innovation.

FAQs

Q: What is the main subject of United States Patent 9,089,534? A: The main subject is a pharmaceutical semi-solid composition of isotretinoin.

Q: How can the scope of a patent be measured? A: The scope can be measured using metrics such as independent claim length and independent claim count.

Q: What is the purpose of the Global Dossier service? A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to view the patent family and related documents.

Q: Why are narrower claims often preferred? A: Narrower claims are often preferred because they are associated with a higher probability of grant, a shorter examination process, and reduced licensing and litigation costs.

Q: How can one search for prior art related to a patent? A: One can use tools like the Patent Public Search, Common Citation Document (CCD), and international patent databases such as PATENTSCOPE.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. PubChem - Pharmaceutical semi-solid composition of isotretinoin. Retrieved from https://pubchem.ncbi.nlm.nih.gov/patent/US9089534
  3. SSRN - Patent Claims and Patent Scope. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Clemson University - Advanced Patent Searching. Retrieved from https://clemson.libguides.com/advanced_patent_searching
  5. US Patent - Pharmaceutical semi-solid composition of isotretinoin. Retrieved from https://patentimages.storage.googleapis.com/19/bf/de/0d0744f28c8560/US9089534.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,089,534

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.